Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development

The emergence and spread of parasite resistance to currently available antimalarials has highlighted the importance of developing novel antimalarials. This scoping review provides an overview of antimalarial drug candidates undergoing phase I and II studies between 1 January 2016 and 28 April 2021....

Descripción completa

Detalles Bibliográficos
Autores principales: Abd-Rahman, Azrin N., Zaloumis, Sophie, McCarthy, James S., Simpson, Julie A., Commons, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846400/
https://www.ncbi.nlm.nih.gov/pubmed/34843390
http://dx.doi.org/10.1128/aac.01659-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846400/
https://www.ncbi.nlm.nih.gov/pubmed/34843390
http://dx.doi.org/10.1128/aac.01659-21

Ejemplares similares